3088912
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unisr.it/resource/item/38946

Document
type: Class

3088911
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unisr.it/resource/item/38946

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T07:21:38
publisher: http://irises.unisr.it/resource/item/38946
type: Document
label: RDF description of Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis - http://irises.unisr.it/resource/item/38946

3088942
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unisr.it/resource/item/38946

Generically Dependent Continuant
type: Class

3088941
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unisr.it/resource/item/38946

Article
type: Class

Information Content Entity
type: Class

http://irises.unisr.it/resource/item/38946
type: Generically Dependent Continuant
type: Continuant
most specific type: Academic Article
type: Entity
related by: 3088912
label: Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis
type: Thing
related by: 3088911
type: Article
type: Document
type: Information Content Entity
related by: 3088942
type: Academic Article
related by: 3088941